HCAR - Hershey Center for Applied Research. South Centrals Pennsylvania's Premier Research Park Located Adjacent to Penn State Milton S. Hershey Medical Center and College of Medicine.

ClawNor

ClawNor, an early-stage company focused on producing reagents for diagnosis and therapy of human papillomavirus (HPV) infection was incorporated in 1996 and until recently was focused on consulting services.

The company will soon begin production of established monoclonal antibodies for type specific recognition of HPV. A number of R43 applications are pending that are focused on development of aptamers for recognition of HPV-infected cells and type-specific recognition of HPV types, with the ultimate goal of replacing the monoclonal antibodies with more affordable and widely available aptamers. ClawNor presently holds one U.S. patent for a topical therapeutic reagent which shows promising efficacy for the eradication of HPV infections. The company expects to employ 4-5 researchers within the next year.